A Phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma

Cancer ◽  
2002 ◽  
Vol 95 (8) ◽  
pp. 1714-1719 ◽  
Author(s):  
Irina E. Popa ◽  
Kathleen Stewart ◽  
Frederick P. Smith ◽  
Naiyer A. Rizvi
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma

Cancer ◽  
2002 ◽  
Vol 95 (6) ◽  
pp. 1274-1278 ◽  
Author(s):  
David A. Rinaldi ◽  
Nancy A. Lormand ◽  
Joseph E. Brierre ◽  
James L. Cole ◽  
Brian C. Barnes ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma ◽  
Previously Treated

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

Cancer ◽  
2002 ◽  
Vol 95 (7) ◽  
pp. 1520-1527 ◽  
Author(s):  
Mark A. Socinski ◽  
Alan B. Sandler ◽  
Valerie K. Israel ◽  
Heidi H. Gillenwater ◽  
Langdon L. Miller ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Stage Iiib ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals Phase II trial of weekly docetaxel in second-line therapy for nonsmall cell lung carcinoma

Cancer ◽  
2001 ◽  
Vol 92 (8) ◽  
pp. 2158-2163 ◽  
Author(s):  
Rogerio C. Lilenbaum ◽  
Michael A. Schwartz ◽  
Leonard Seigel ◽  
Francisco Belette ◽  
Arnold Blaustein ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
Second Line ◽  
Second Line Therapy ◽  
Cell Lung Carcinoma ◽  
Weekly Docetaxel ◽  
Nonsmall Cell Lung Carcinoma ◽  
Line Therapy

scholarly journals Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial

Cancer ◽  
2000 ◽  
Vol 89 (4) ◽  
pp. 763-768 ◽  
Author(s):  
Emilio Bajetta ◽  
Simonetta Chiara Stani ◽  
Daniela De Candis ◽  
Paolo Bidoli ◽  
Luigi Mariani ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Trial ◽  
First Line ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma ◽  
Line Chemotherapy

scholarly journals Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (12) ◽  
pp. 2759-2765 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Sung Young Lee ◽  
Chun Gun Park ◽  
Hyae Young Kim ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2003 ◽  
Vol 98 (9) ◽  
pp. 1918-1924 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Hae Young Kim ◽  
Eun Kyung Hong ◽  
Sung Min Yoon ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Weekly Docetaxel ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

Cancer ◽  
2000 ◽  
Vol 89 (4) ◽  
pp. 774-782 ◽  
Author(s):  
Christos Kosmas ◽  
Nicolas B. Tsavaris ◽  
Aristidis Polyzos ◽  
Haralambos P. Kalofonos ◽  
Evangelos Sepsas ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document